An uncommon response to metronomic therapy in a heavily pretreated patient with metastatic carcinosarcoma: a case report. (December 2016)

• Record Type: Journal Article
• Authors: Gagliato, Debora; Linck, Rudinei; Bezerra, Regis; Souto, Mirela; Lopes, Gabriel; Baiocchi, Glauco; Mano, Max
• Is Part Of: Journal of medical case reports. Volume 10:Number 1(2016)
• Page Start: 1
• Page End: 4
• Publication Date: 2016-12
• Subjects: Uterine carcinosarcoma -- Metronomic chemotherapy -- Antiangiogenic therapy; Medicine -- Research -- Periodicals; Medicine -- Case studies -- Periodicals; 610.5
• DOI: 10.1186/s13256-016-0837-3
• Languages: English
• ISSNs: 1752-1947

Abstract

Abstract Background Uterine carcinosarcoma is well known for its aggressive behavior. There is little evidence regarding the gold standard combination chemotherapy in metastatic or locally advanced carcinosarcoma, due to poor survival outcomes obtained with conventional scheduled chemotherapy. This case report represents the first-ever reported objective response to a metronomic chemotherapy regimen and adds to the current literature. Case presentation We describe a case of a Caucasian woman diagnosed with metastatic carcinosarcoma that had already been treated with multiple lines of conventional chemotherapy, with progressive disease. This patient had a surprising clinical and imaging response when treated with oral metronomic cyclophosphamide. Conclusions We reviewed the mechanism of action implicated in metronomic chemotherapy, and correlated it with the biology of disease in carcinosarcoma. This information may add to the current literature, providing important insights to future clinical trials in this patient population.